Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool August 13, 2004 Tom Gardner	Should You Own 50 Stocks? The majority of individual investors in stocks are still in learning mode and should have very diversified portfolios.
The Motley Fool August 9, 2004 Tom Gardner	How to Find Great Small Caps A discussion on small-cap investing framework.
The Motley Fool August 11, 2004 Tom Gardner	Cheering the Market Drop Market declines, like the one we're now enduring, present opportunities for net buyers of stocks. Yet still, it comes down to doing the due diligence analytical work on each business and stock before buying.
The Motley Fool August 4, 2004 Tom Gardner	3 Rising Stars Principles of investing in small-cap stocks and some industry examples: Marine Products Corp... Healthcare Services Group... Craftmade... etc.
The Motley Fool February 12, 2004 Selena Maranjian	Screen for Great Stocks Learn to screen and you may just uncover some big moneymakers.
The Motley Fool May 26, 2004 Tom Gardner	Finding Lynch's 10-Baggers There's a method to finding tomorrow's home runs. The author has made it his mission to uncover the best underfollowed, underappreciated companies before Wall Street gets on board.
The Motley Fool October 1, 2004 Rich Smith	The Science of Stock Picking Heisenberg's theory has implications not only for predicting the position and momentum of particles, but also for an investor's ability to know and predict a stock's current and future valuations.
The Motley Fool January 24, 2010 Matt Koppenheffer	How Long Should You Ride This Rally? This rally has been a great ride, but is it time to hop off?
The Motley Fool April 7, 2004 Gardner & Moore	Small Stocks, Big Gains Here's the philosophy behind the successful Hidden Gems investing strategy.
The Motley Fool October 12, 2010 Selena Maranjian	Don't Underestimate These Great Stocks Companies with rock-bottom P/Es could be true bargains.
The Motley Fool March 17, 2004 Tom Gardner	Home Run Stock Redux Tom Gardner refines his search for the market's true hidden gems. Many of the decade's greatest investments rose to prominence from relative obscurity. Tom Gardner has made it his mission to uncover the greatest stocks for the next 10 years.
The Motley Fool August 5, 2004 Rich Smith	Sportsman's Guide to Insider Selling Sportsman's Guide just turned in its second quarter 2004 results, and while Wall Street reacted with scorn the numbers were quite impressive.
The Motley Fool September 8, 2004 James Early	3 Stocks Worth Watching Here are a few tactics for finding the hidden gems of the market, along with three companies to watch.
The Motley Fool August 4, 2009 Matt Koppenheffer	How Long Should You Ride This Rally? This rally in the market has been a great ride, but is it time to hop off?
The Motley Fool September 8, 2004 Bill Mann	The Self-Confidence of the Naive So many investors believe that they can generate above-average returns by concentrating on things that the market has already priced in. Better to look out longer term, where few others are.
The Motley Fool December 22, 2009 Matt Koppenheffer	How Long Should You Ride This Rally? Our concern shouldn't be how much the market has gone up or down, but rather whether its valuation is attractive or unattractive.
The Motley Fool January 28, 2005 Rich Duprey	Chiron: What Would Warren Do? Have the pharmaceutical company's vaccine woes made it a Buffett-worthy investment yet?
The Motley Fool September 16, 2004 Jim Schoettler	Bargain Hunting How to find values in beaten-down stocks. Here are five steps that help you separate the dazzlers from the duds.
The Motley Fool April 20, 2004 Rex Moore	Small-Cap Rally Roars Because small-cap stocks have done so well over the past year, many are wondering if it's time to shift gears and allocate more money to larger companies. That type of thinking, however, can lead to subpar returns.
The Motley Fool June 24, 2004 Tim Beyers	What Tech Bubble? The author disagrees that tech's highly overvalued. Investing in technology has long been a highly risky but profitable endeavor.
The Motley Fool June 10, 2004 Rich Smith	Does JoS. A. Bank Measure Up? How does the fast-growing clothier hold up to a Hidden Gems appraisal?
The Motley Fool January 13, 2005 Gardner & Moore	Danger! Horror! Get Out! The traits of bad small businesses that make us fear and loathe them as investments.
The Motley Fool September 17, 2004 Rich Smith	Hit 'Em Where They Ain't By focusing your investing on small caps, you can go where the giants of the investing world can't.
BusinessWeek May 3, 2004 Lauren Young	Small-Caps That Still Want You Many hot small-company stock funds are closed to newcomers. Check out these small-cap funds that still welcome new investors.
The Motley Fool December 11, 2006 Michael P. Cecil	Why Doesn't Buffett Buy Drug Companies? Investors, how do you estimate the amount of money that a drug company, or perhaps more simply one of its drugs, will produce over its lifetime?
The Motley Fool August 12, 2010 Jordan DiPietro	7 Burned-Out Drug Stocks These 5-star drug stocks have been beaten down to attractive levels.
The Motley Fool May 24, 2011 Amanda B. Kish	This ETF Sector Is Getting Pricey While large-cap stocks dominated in the late 1990s, small-cap stocks have had a truly amazing run in the decade since then.
The Motley Fool August 10, 2004 Tom Gardner	10-Bagger Magic How to succeed in small-cap investing despite the inevitable losers.
The Motley Fool November 16, 2009 Matt Koppenheffer	How Long Should You Ride This Rally? This rally has been a great ride, but is it time to hop off?
The Motley Fool April 28, 2004 Tom Gardner	Focus! Focus! Focus! Diversification is usually a road to mediocrity for small companies. The truly great ones stay focused. Operational focus is crucial to the success of most every small company in the world. Invest accordingly.
The Motley Fool March 2, 2005 Tom Gardner	The Next Home Run Stock Tomorrow's huge winners are out there today. The trick is finding them. Many of the decade's greatest investments rose to prominence from relative obscurity.
The Motley Fool October 22, 2004 Tom Gardner	The Next Home Run Stock Tomorrow's huge winners are out there today. The trick is finding them. Many of the decade's greatest investments rose to prominence from relative obscurity.
The Motley Fool November 5, 2004 Tim Beyers	Penny Stocks From Heaven Sure, many penny stocks are bad. But some of them offer divine returns for the money-wise bargain hunter.
The Motley Fool August 23, 2004 Bill Mann	Google: The Scorecard The most anticipated IPO in history has passed. After all the hype and garment rending, how'd it go?
The Motley Fool June 3, 2004 Ben McClure	Eyeing European Stock European technology stocks are cheaper than their U.S. peers. What gives?
The Motley Fool July 2, 2004 Whitney Tilson	The Joy of Cash This mutual fund manager scours the investment universe regularly, but says he's found few good values. So he coolly bides his time and holds onto his cash. Should he worry? Several other respected funds are holding cash too.
The Motley Fool April 14, 2004 Paul Elliott	Smart Money, Killer Stocks Hidden Gems purist Paul Elliott takes a look inside small-cap investing. For all that, there are things to look for. Insider ownership, for one, is easy to screen for but more nuanced than you might think.
The Motley Fool October 1, 2004 Jim Mueller	Fortune's 100 Most Doomed? Fortune Magazine's annual list of the 100 Fastest Growing Companies gives us the hottest companies of the year. Will buying them now be a rewarding experience going forward?
Financial Planning February 1, 2005	Mutual Fund Monitor Assessing Assets: Domestic equities... Growth stocks... Small caps... Investment-grade bonds... etc.
The Motley Fool February 9, 2005 Rich Smith	Hunting Baby Elephants Wouldn't you like to find -- and buy -- tomorrow's 6-ton business behemoths while they're still small? Here's how to do it.
Registered Rep. March 1, 2005 David A. Twibell	What Ails You? Investors who are wary of big pharma investments have good reasons to be. But this does not mean that the sector is to be avoided at all costs. Indeed, for savvy, well-informed investors, now might be a good time to jump in.
The Motley Fool October 13, 2009 Matt Koppenheffer	How Long Should You Ride This Rally? This rally has been a great ride, but is it time to hop off?
The Motley Fool August 16, 2004 Matt Logan	Lessons From the Value Trust Legg Mason's Mary Chris Gay, talks about her investment philosophy and how she searches for promising ideas and evaluates companies for the Legg Mason Value Trust Fund.
The Motley Fool July 16, 2007 Amanda B. Kish	Large Caps Making a Comeback? So how can smart investors best capitalize on any coming large-cap rebound? Well, don't abandon small caps completely.
The Motley Fool March 22, 2010 Matt Koppenheffer	How Long Should You Ride This Rally? This rally has been a great ride, but is it time to hop off? Our concern shouldn't be how much the market has gone up or down, but rather whether its valuation is attractive or unattractive.
The Motley Fool May 27, 2004	Why Companies Split Stock Don't get excited when a stock of yours splits -- it's no big deal.
The Motley Fool February 20, 2010 Matt Koppenheffer	How Long Should You Ride This Rally? This rally has been a great ride, but is it time to hop off?
The Motley Fool September 21, 2006 Tim Hanson	This Is Why You Don't Stand on the Sidelines The size of a company has a great deal to do with what you can expect to get out of the stock. ... Specific products aside, big companies don't have big stock moves. Investors, think small to get ahead.
The Motley Fool July 8, 2005 Lawrence Meyers	Good Growth at Weight Watchers It may not be a small cap, but with these net margins, its return on equity, and the earnings growth, Weight Watchers' stock price may still have room to bulk up.
The Motley Fool February 22, 2005 Charly Travers	Is Big Pharma a Bargain? While much of the drug sector is looking pretty tasty, Pfizer, with its attractive relative valuation, dominant marketing presence, and willingness to buy up blockbuster drugs, heads the list.